K. Rosanna

1.6k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

K. Rosanna is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, K. Rosanna has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in K. Rosanna's work include RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and CRISPR and Genetic Engineering (2 papers). K. Rosanna is often cited by papers focused on RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and CRISPR and Genetic Engineering (2 papers). K. Rosanna collaborates with scholars based in United States, France and Sweden. K. Rosanna's co-authors include Gregor Bieri, Aaron D. Gitler, Paymaan Jafar‐Nejad, Hong Joo Kim, Frank Rigo, Lindsay A. Becker, David A. Knowles, Georg Auburger, James Messing and Armand Soriano and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

K. Rosanna

13 papers receiving 1.1k citations

Hit Papers

Therapeutic reduction of ataxin-2 extends lifespan and re... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
    2017 396 citations Lindsay A. Becker, Gregor Bieri et al. Nature profile →

Peers

K. Rosanna
Hitomi Tsuiji Japan
Seth H. Cassel United States
Matteo Cereda Italy
Chunxing Yang United States
Xingli Li United States
Constantin d’Ydewalle Belgium
Violaine Harris United States
Yohei Iguchi Japan
Tamara Major Serbia
Nisha M. Badders United States
Hitomi Tsuiji Japan
K. Rosanna
Citations per year, relative to K. Rosanna K. Rosanna (= 1×) peers Hitomi Tsuiji

Countries citing papers authored by K. Rosanna

Since Specialization
Citations

This map shows the geographic impact of K. Rosanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Rosanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Rosanna more than expected).

Fields of papers citing papers by K. Rosanna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Rosanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Rosanna. The network helps show where K. Rosanna may publish in the future.

Co-authorship network of co-authors of K. Rosanna

This figure shows the co-authorship network connecting the top 25 collaborators of K. Rosanna. A scholar is included among the top collaborators of K. Rosanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Rosanna. K. Rosanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Long, Donald, Marina Chan, K. Rosanna, et al.. (2024). Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma. Cell Reports Medicine. 5(9). 101699–101699. 1 indexed citations
2.
Rosanna, K., Matt Kanke, John D. Gordan, et al.. (2024). DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. PLoS Genetics. 20(3). e1011216–e1011216. 4 indexed citations
3.
Dinh, Timothy A., Alan F. Utria, Kevin C. Barry, et al.. (2022). A framework for fibrolamellar carcinoma research and clinical trials. Nature Reviews Gastroenterology & Hepatology. 19(5). 328–342. 22 indexed citations
4.
Kycia, Ina, K. Rosanna, Evan A. Bordt, et al.. (2022). DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling. PLoS ONE. 17(2). e0263829–e0263829. 8 indexed citations
5.
Dinh, Timothy A., F. Donelson Smith, Adam B. Francisco, et al.. (2020). Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities. Cell Reports. 31(2). 107509–107509. 23 indexed citations
6.
Murray, Christopher W., Jennifer J. Brady, Min K. Tsai, et al.. (2019). An LKB1–SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation. Cancer Discovery. 9(11). 1590–1605. 62 indexed citations
7.
Bieri, Gregor, Michel Brahic, Luc Bousset, et al.. (2019). LRRK2 modifies α-syn pathology and spread in mouse models and human neurons. Acta Neuropathologica. 137(6). 961–980. 137 indexed citations
8.
Caswell, Deborah R., Chen-Hua Chuang, K. Rosanna, et al.. (2018). Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma. Molecular Cancer Research. 16(11). 1737–1749. 35 indexed citations
9.
Kramer, Nicholas J., Michael S. Haney, David W. Morgens, et al.. (2018). CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nature Genetics. 50(4). 603–612. 160 indexed citations
10.
Chiou, Shin-Heng, Viviana I. Risca, Gordon Wang, et al.. (2017). BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Cancer Discovery. 7(10). 1184–1199. 49 indexed citations
11.
Winters, Ian P., Shin-Heng Chiou, Nicole K. Paulk, et al.. (2017). Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nature Communications. 8(1). 2053–2053. 59 indexed citations
12.
Becker, Lindsay A., Gregor Bieri, K. Rosanna, et al.. (2017). Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 544(7650). 367–371. 396 indexed citations breakdown →
13.
Greenside, Peyton, Zoe Rogers, Jennifer J. Brady, et al.. (2017). Molecular definition of a metastatic lung cancer state reveals a targetable CD109–Janus kinase–Stat axis. Nature Medicine. 23(3). 291–300. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitomi Tsuiji Breakdown of academic impact, for papers by Seth H. Cassel Breakdown of academic impact, for papers by Matteo Cereda Breakdown of academic impact, for papers by Chunxing Yang Breakdown of academic impact, for papers by Xingli Li Breakdown of academic impact, for papers by Constantin d’Ydewalle Breakdown of academic impact, for papers by Violaine Harris Breakdown of academic impact, for papers by Yohei Iguchi Breakdown of academic impact, for papers by Tamara Major Breakdown of academic impact, for papers by Nisha M. Badders
Rankless by CCL
2026